The Utility of Brief Cognitive Tests for Patients With Type 2 Diabetes Mellitus: A Systematic Review

Journal of the American Medical Directors Association

Volumn 17, Issue 10, 2016, Pages 889-895

  Dong, YanHong ^a,b   Kua, Zhong Jie ^c,d   Khoo, Eric Yin Hao ^c,e   Koo, Edward H ^e,f   Merchant, Reshma A ^c,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Dept Medicine Endocrinol Diabet   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Brief cognitive tests; systematic review; type 2 diabetes mellitus

Indexed keywords

CLINICAL DEMENTIA RATING; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; DEMENTIA; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIGIT SYMBOL SUBSTITUTION TEST; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; REVIEW; REY AUDITORY VERBAL LEARNING TEST; SCREENING TEST; SYSTEMATIC REVIEW; TELEPHONE INTERVIEW; TEST YOUR MEMORY; ADULT; AGED; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84995685482     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.06.010     Document Type: Review

References (52)

1. 1 Cheng, G., Huang, C., Deng, H., Wang, H., Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Internal Med J 42 (2012), 484–491.
2. 2 Biessels, G.J., Strachan, M.W., Visseren, F.L., et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: Towards targeted interventions. Lancet Diabetes Endocrinol 2 (2014), 246–255.
3. 3 Van den Berg, E., Reijmer, Y.D., De Bresser, J., et al. Utrecht Diabetic Encephalopathy Study Group. A 4-year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53 (2010), 58–65.
4. 4 Reijmer, Y.D., van den Berg, E., Ruis, C., et al. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26 (2010), 507–519.
5. 5 Van den Berg, E., De Craen, A.J., Biessels, G.J., et al. The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia 49 (2006), 2015–2023.
6. 6 Biessels, G.J., Staekenborg, S., Brunner, E., et al. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5 (2006), 64–74.
7. 7 Ruis, C., Biessels, G.J., Gorter, K.J., et al. Cognition in the early stage of type 2 diabetes. Diabetes Care 32 (2009), 1261–1265.
8. 8 Palta, P., Schneider, A.L., Biessels, G.J., et al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc 20 (2014), 278–291.
9. 9 Sadanand, S., Balachandar, R., Bharath, S., Memory and executive functions in persons with type 2 diabetes: A meta-analysis. Diabetes Metab Res Rev 32 (2016), 132–142.
10. 10 Kodl, C.T., Seaquist, E.R., Cognitive dysfunction and diabetes mellitus. Endocrine Rev 29 (2008), 494–511.
11. 11 Messier, C., Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 26 (2005), 26–30.
12. 12 Awad, N., Gagnon, M., Messier, C., The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26 (2004), 1044–1080.
13. 13 Kanaya, A.M., Barrett-Connor, E., Gildengorin, G., Yaffe, K., Change in cognitive function by glucose tolerance status in older adults: A 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164 (2004), 1327–1333.
14. 14 Bruce, D.G., Casey, G.P., Grange, V., et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: The Fremantle Cognition in Diabetes Study. Diabetes Res Clin Pract 61 (2003), 59–67.
15. 15 Biessels, G.J., van der Heide, L.P., Kamal, A., et al. Ageing and diabetes: Implications for brain function. Eur J Pharmacol 441 (2002), 1–14.
16. 16 Grodstein, F., Chen, J., Wilson, R.S., Manson, J.E., Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24 (2001), 1060–1065.
17. 17 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151 (2009), 264–269.
18. 18 Abbatecola, A.M., Rizzo, M.R., Barbieri, M., et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 67 (2006), 235–240.
19. 19 Christman, A.L., Vannorsdall, T.D., Pearlson, G.D., et al. Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample. Arch Clin Neuropsychol 25 (2010), 49–59.
20. 20 Yamazaki, Y., Miwa, T., Sakurai, H., et al. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocrine J 58 (2011), 109–115.
21. 21 Koekkoek, P.S., Rutten, G.E., van den Berg, E., et al. The “Test Your Memory” test performs better than the MMSE in a population without known cognitive dysfunction. J Neurol Sci 328 (2013), 92–97.
22. 22 Okereke, O.I., Kang, J.H., Cook, N.R., et al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc 56 (2008), 1028–1036.
23. 23 Sinclair, A.J., Gadsby, R., Hillson, R., et al. Brief report: Use of the Mini-Cog as a screening tool for cognitive impairment in diabetes in primary care. Diabetes Res Clin Pract 100 (2013), e23–e25.
24. 24 Alagiakrishnan, K., Zhao, N., Mereu, L., et al. Montreal Cognitive Assessment is superior to Standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Bio Med Res Int, 1861, 2013, 5.
25. 25 Özcan, T., Demir, E.Y., Investigation the cognitive impairment in diabetes mellitus type 2 with Moca Test. J Psychiatry, 17, 2014, 2.
26. 26 Noel-Storr, A.H., McCleery, J.M., Richard, E., et al. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. Neurology 83 (2014), 364–373.
27. 27 Chung, C.C., Pimentel, D., Jor'dan, A.J., et al. Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology 85 (2015), 450–458.
28. 28 Ebady, S.A., Arami, M.A., Shafigh, M.H., Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract 82 (2008), 305–309.
29. 29 Yaffe, K., Falvey, C., Hamilton, N., et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69 (2012), 1170–1175.
30. 30 Lai, Y.R., Yang, Y.S., Tsai, M.L., et al. Benzodiazepine and nonbenzodiazepine prescriptions for Taiwanese elderly with type 2 diabetes contributes to cognitive dysfunction. Int Psychogeriatr 26 (2014), 1719–1727.
31. 31 Dore, G.A., Elias, M.F., Robbins, M.A., et al. Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: The Maine–Syracuse Study. Diabetologia 52 (2009), 2551–2560.
32. 32 Wang, Y., Xu, X.Y., Feng, C.H., et al. Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus. Metab Brain Dis 30 (2015), 1027–1034.
33. 33 Zhang, Y.W., Zhang, J.Q., Liu, C., et al. Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes. Chinese Med J, 128, 2015, 465.
34. 34 Wang, C.X., Fu, K.L., Liu, H.J., et al. Spontaneous brain activity in type 2 diabetics revealed by amplitude of Low-frequency fluctuations and its association with diabetic vascular disease: A resting-state fMRI study. PloS One, 9, 2014, e108883.
35. 35 Launer, L.J., Miller, M.E., Williamson, J.D., et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol 10 (2011), 969–977.
36. 36 Abbatecola, A.M., Lattanzio, F., Molinari, A.M., et al. Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. Diabetes Care 33 (2010), 1706–1711.
37. 37 van Bussel, F.C., Backes, W.H., Hofman, P.A., et al. On the interplay of microvasculature, parenchyma, and memory in type 2 diabetes. Diabetes Care 38 (2015), 876–882.
38. 38 Hugenschmidt, C.E., Lovato, J.F., Ambrosius, W.T., et al. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care 37 (2014), 3244–3252.
39. 39 Wennberg, A.M., Gottesman, R.F., Kaufmann, C.N., et al. Diabetes and cognitive outcomes in a nationally representative sample: The National Health and Aging Trends Study. Int Psychogeriatr 26 (2014), 1729–1735.
40. 40 Trzepacz, P.T., Hochstetler, H., Wang, S., et al. Relationship between the Montreal Cognitive Assessment and Mini-Mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr, 15, 2015, 107.
41. 41 Lonie, J.A., Tierney, K.M., Ebmeier, K.P., Screening for mild cognitive impairment: A systematic review. Int J Geriatr Psychiatry 24 (2009), 902–915.
42. 42 Spencer, R.J., Wendell, C.R., Giggey, P.P., et al. Psychometric limitations of the Mini-Mental State Examination among nondemented older adults: An evaluation of neurocognitive and magnetic resonance imaging correlates. Exp Aging Res 39 (2013), 382–397.
43. 43 Smith, M.A., Else, J.E., Paul, L., et al. Functional living in older adults with type 2 diabetes executive functioning, dual task performance, and the impact on postural stability and motor control. J Aging Health, 26, 2014, 841.
44. 44 Yeung, S.E., Fischer, A.L., Dixon, R.A., Exploring effects of type 2 diabetes on cognitive functioning in older adults. Neuropsychology, 23, 2009, 1.
45. 45 Hazari, M.A.H., Reddy, B.R., Uzma, N., Kumar, B.S., Cognitive impairment in type 2 diabetes mellitus. Int J Diabetes Mellitus 3 (2015), 19–24.
46. 46 West, R.K., Ravona-Springer, R., Schmeidler, J., et al. The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control. Am J Geriatr Psychiatry 22 (2014), 1055–1059.
47. 47 Tariq, S.H., Tumosa, N., Chibnall, J.T., et al. Comparison of the Saint Louis University mental status examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry 14 (2006), 900–910.
48. 48 Kaya, D., Isik, A.T., Usarel, C., et al. The Saint Louis University Mental Status Examination Is Better than the Mini-Mental State Examination to determine the cognitive impairment in Turkish elderly people. J Am Med Dir Assoc 17 (2016), 370.e11–370.e15.
49. 49 Cao, L., Hai, S., Lin, X., et al. Comparison of the Saint Louis University Mental Status Examination, the Mini-Mental State Examination, and the Montreal Cognitive Assessment in detection of cognitive impairment in Chinese elderly from the geriatric department. J Am Med Dir Assoc 13 (2012), 626–629.
50. 50 Malmstrom, T.K., Voss, V.B., Cruz-Oliver, D.M., et al. The Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 19 (2015), 741–744.
51. 51 Kennedy, R.E., Wadley, V.G., McClure, L.A., et al. Performance of the NINDS-CSN 5-minute protocol in a national population-based sample. J Int Neuropsycholl Soc 20 (2014), 856–867.
52. 52 Salak Djokić, B., Spitznagel, M.B., Pavlović, D., et al. Diabetes mellitus and cognitive functioning in a Serbian sample. J Clin Exp Neuropsychol 37 (2015), 37–48.